Evaluation of lateral flow immunoassays for detection of Rubella IgM — WHO

Original title: REOI for WHO Evaluation of lateral flow immunoassays (LFTs) for Detection of Rubella IgM for Surveillance

Published on March 31, 2026 at 02:42 AMModified on March 31, 2026 at 02:42 AM

Key information

Type: Health
Location: Multiple countries
Estimated Value: Not disclosed
Language of Notice: English

What is this tender about?

Evaluation of lateral flow immunoassays for detection of Rubella IgM — WHO is a health procurement opportunity published by OMS in Multiple countries on March 31, 2026. 1 official document is attached below.

REOI for WHO Evaluation of lateral flow immunoassays (LFTs) for Detection of Rubella IgM for Surveillance WHO REOI for WHO Evaluation of lateral flow immunoassays (LFTs) for Detection of Rubella IgM for Surveillance Request for EOI Reference: 2026-EOI-BP-23_ Rubella Beneficiary countries or territories: Multiple destinations (see the Countries or territories tab) Registration level: Basic Published on: 27-Feb-2026 Deadline on: 15-Apr-2026 17:00 (GMT 1.00) Description The World Health Organization (WHO) invites vendors to submit an Expression of Interest (EOI) for a WHO EVALUATION OF LATERAL FLOW IMMUNOASSAYS FOR THE DETECTION OF RUBELLA IgM FOR SURVEILLANCE which address the following objectives: Ensure continued availability of Rubella in vitro diagnostics that enable early outbreak detection and assessment of Rubella risks.

Improve access to accurate, reliable Rubella LFTs in high‑risk countries to support timely outbreak response and vaccination planning. Assess whether commercial products meet WHO standards for safety, quality, and performance for use in Rubella surveillance. Include eligible LFTs that are single‑use, inst

Procuring Entity

Name: OMS

Which documents are available?

Sign in to download the tender documents and be notified automatically of any change to this tender.

Bidding Document